Seamac Formulations Private Limited - Due diligence report

A 360° intelligence report on Seamac Formulations Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2007-01-22 Talwara, Punjab Active Unlisted Active Compliant
Share
SF Seamac Formulations Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Seamac Formulations Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
84/100
Trust Score
Low Risk

Seamac Formulations Private Limited is assessed as Low Risk with a Trust Score of 84/100. Seamac Formulations Private Limited is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Seamac Formulations Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Profitable - internal accruals available.

Charges position: 2 open (1.73 cr) · 6 satisfied (91.50 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Others6 48.0 cr
Punjab National Bank1 48.0 cr
Panjab National Bank1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 3 auditor resignation(s) filed - latest: Praveen Chand & co. on 2021-06-10.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUDHIR SHARMA 01234567 Director 01/04/2018 6 yrs Approved
ABHISHEK SHARMA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 8 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 19+ years.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
2 open charge(s) registered - assets are encumbered.
3 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 1.73 cr already registered.
  • Compliance record supports lending.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
23 Apr 2025
Charge satisfied
Panjab National Bank
22 Apr 2025
Charge satisfied
Others
21 Apr 2025
Charge satisfied
Others
21 Mar 2025
Charge created
Others - 75.00 Lakh
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
09 Jan 2023
Charge created
Others - 10.00 Lakh
31 Mar 2022
Share transfer (FY 2022)
80000.00000000 shares to Abhishek Sharma
Share transfer (FY 2022)
80000.00000000 shares to Ram Naresh Bhardwaj
29 Sep 2021
Charge created
Others - 50.00 Lakh
25 Jun 2020
Charge created
Others - 5.00 Lakh
10 Jun 2020
Charge created
Others - 4.00 Lakh
24 May 2019
Director ceased
UMA BHARDWAJ
20 May 2019
Director appointed
ABHISHEK SHARMA (Director)
31 Mar 2017
Share transfer (FY 2017)
6000.00000000 shares to SUDHIR
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Maskon Life Sciences Private Limited U33100UR2018PTC009027 Haridwar, Uttarakhand, India
Bio Trans Pharmaceuticals Private Limited U24231TN1989PTC018382 Athipattu, Tamil Nadu, India
Eurofrits India Private Limited U26999GJ2021PTC125150 Ahmedabad, Gujarat, India
Caplin One Labs Limited U24299TN2021PLC143869 Chennai, Tamil Nadu, India
Pharmawind Healthcare Private Limited U24239GJ2019PTC106440 Surat, Gujarat, India
Captavis Biocare Private Limited U24290GJ2021PTC121485 Bavla, Gujarat, India
Invision Pharma Limited U24304KA2018PLC113264 Bengaluru, Karnataka, India
Solariz Healthcare Private Limited U24299TN2020PTC140155 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Seamac Formulations Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Seamac Formulations Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Seamac Formulations Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Seamac Formulations Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Seamac Formulations Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Seamac Formulations Private Limited an active company?

Seamac Formulations Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Seamac Formulations Private Limited financially healthy?

Seamac Formulations Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Seamac Formulations Private Limited?

Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Seamac Formulations Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Seamac Formulations Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.

Is Seamac Formulations Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Seamac Formulations Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.